{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:37:01Z","timestamp":1790303821336,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","canadianjournalofophthalmology.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jcjo.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T19:45:42Z","timestamp":1718480742000},"page":"e133-e143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcomes of noninfectious uveitis treated with systemic immunomodulatory therapy: a retrospective case series"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0927-3086","authenticated-orcid":false,"given":"Tina","family":"Felfeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5948-0331","authenticated-orcid":false,"given":"Michael","family":"Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0652-6946","authenticated-orcid":false,"given":"Felicia","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0047-8157","authenticated-orcid":false,"given":"Arshia","family":"Eshtiaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8515-3668","authenticated-orcid":false,"given":"Panos G.","family":"Christakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrem D.","family":"Mandelcorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupura K.","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa A.","family":"Derzko-Dzulynsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2024.05.005_bib0001","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","article-title":"New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review","volume":"49","author":"Rosenbaum","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0002","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5301\/ejo.5000278","article-title":"Review on the worldwide epidemiology of uveitis","volume":"23","author":"Miserocchi","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0003","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/09286580802478724","article-title":"Epidemiology of uveitis","volume":"15","author":"Wakefield","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0004","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17469899.2018.1477590","article-title":"Novel therapies in the treatment of noninfectious uveitis","volume":"13","author":"Sandhu","year":"2018","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0005","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/14740338.2019.1692810","article-title":"Safety of systemic therapy for noninfectious uveitis","volume":"18","author":"Ormaechea","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0006","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/09273948.2019.1687733","article-title":"Visual acuity outcome over time in non-infectious uveitis","volume":"29","author":"Pistilli","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00655","article-title":"New pharmacological strategies for the treatment of non-infectious uveitis. A minireview","volume":"11","author":"Valenzuela","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0008","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/17469899.2017.1319762","article-title":"Comparative efficacy of steroid-sparing therapies for non-infectious uveitis","volume":"12","author":"Knickelbein","year":"2017","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0009","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s10792-021-01763-8","article-title":"New pharmacotherapy options for noninfectious posterior uveitis","volume":"41","author":"Pleyer","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cca.2010.04.017","article-title":"Uveitis: Mechanisms and recent advances in therapy","volume":"411","author":"Srivastava","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0011","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ophtha.2010.03.029","article-title":"A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States","volume":"118","author":"Nguyen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajo.2021.03.061","article-title":"The Standardization of Uveitis Nomenclature (SUN) Working Group. Development of classification criteria for the uveitides","volume":"228","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0013","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0014","doi-asserted-by":"crossref","first-page":"m4979","DOI":"10.1136\/bmj.m4979","article-title":"Uveitis for the non-ophthalmologist","volume":"372","author":"Burkholder","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0015","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/ICU.0000000000000762","article-title":"Multimodal imaging in infectious and noninfectious intermediate, posterior and panuveitis","volume":"32","author":"Thomas","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2010.05.036","article-title":"Scale for photographic grading of vitreous haze in uveitis","volume":"150","author":"Davis","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1869-5760-3-30","article-title":"Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis","volume":"3","author":"Leder","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0019","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ophtha.2021.09.025","article-title":"Efficacy and safety of adalimumab and infliximab for non-infectious uveitis","volume":"129","author":"Tai","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer-related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0022","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2019.12618","article-title":"Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial","volume":"322","author":"Rathinam","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0023","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/ICU.0000000000000562","article-title":"Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics","volume":"30","author":"Thomas","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0024","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/APO.0000000000000371","article-title":"Biologic drugs for the treatment of noninfectious uveitis","volume":"10","author":"Ferreira","year":"2021","journal-title":"Asia-Pacific J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0025","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.39667","article-title":"Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French Uveitis Network","volume":"68","author":"Vallet","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12886-018-0929-5","article-title":"Conventional immunosuppressive therapy in severe Behcet's uveitis: the switch rate to the biological agents","volume":"18","author":"Celiker","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0027","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bjophthalmol-2012-302292","article-title":"Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial","volume":"97","author":"Suhler","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0028","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2009.141","article-title":"Refractory uveitis: 2-year results of a prospective trial","volume":"127","author":"Suhler","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0029","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0031","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3129\/i10-081","article-title":"Practical approach to the use of corticosteroids in patients with uveitis","volume":"45","author":"Cunningham","year":"2010","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0032","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","article-title":"Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis","volume":"115","author":"Sobrin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0033","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2007.132621","article-title":"Treatment of ocular inflammatory conditions with loteprednol etabonate","volume":"92","author":"Pavesio","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0034","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0036","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40257-017-0337-2","article-title":"Malignancy risk and recurrence with psoriasis and its treatments: a concise update","volume":"19","author":"Geller","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102956","article-title":"Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample Mendelian randomization study","volume":"59","author":"Yuan","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0038","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamadermatol.2020.1300","article-title":"Melanoma risk in patients treated with biologic therapy for common inflammatory diseases: a systematic review and meta-analysis","volume":"156","author":"Esse","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0039","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/imj.14215","article-title":"The use of biologic agents in the management of uveitis","volume":"49","author":"Trivedi","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0040","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0041","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tjo.2015.03.004","article-title":"Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention","volume":"5","author":"Hornbeak","year":"2015","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0042","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment Trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0043","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"European Mycophenolate Mofetil Cooperative Study Group . Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0044","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","article-title":"The risk of infections with biologic therapies for rheumatoid arthritis","volume":"39","author":"Furst","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aes-20-80","article-title":"Biologics in non-infectious uveitis past, present and future","volume":"6","author":"Zaki","year":"2021","journal-title":"Ann Eye Sci"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.640473","article-title":"Pathogenesis of non-infectious uveitis elucidated by recent genetic findings","volume":"12","author":"Takeuchi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0047","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.2147\/OPTH.S377358","article-title":"The application of artificial intelligence in the analysis of biomarkers for diagnosis and management of uveitis and uveal melanoma: a systematic review","volume":"16","author":"Bassi","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0048","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/OPTH.S88647","article-title":"Clinical and visual outcomes of patients with uveitis in the mid-Atlantic United States","volume":"9","author":"Bajwa","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.05.005_bib0049","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcjo.2018.03.006","article-title":"Referral characteristics and wait times for uveitis consultation at academic tertiary care centres in Toronto","volume":"53","author":"Felfeli","year":"2018","journal-title":"Can J Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:23:45Z","timestamp":1737681825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418224001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0008418224001418"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.05.005","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of noninfectious uveitis treated with systemic immunomodulatory therapy: a retrospective case series","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}